Work

148 (PB136): UMF814A is a potent, selective and orally bioavailable STK17A inhibitor for MDS/AML

Year: 2024

Type: article

Source: European Journal of Cancer

DOI: 10.1016/j.ejca.2024.114670

Authors: A. Bhalgat, S. Chaudhry, S. Schürer, Y. Feng, J. Taylor

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4403749088

FWCI:

Cites:

Cited by:

Related to: 10